← Back
Data updated: Mar 10, 2026
ALPHARMA US PHARMS
DermatologyRespiratory
ALPHARMA US PHARMS is a generic drug manufacturer focused on Dermatology, Respiratory.
1965
Since
43
Drugs
-
Trials
152
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NYSTATIN 2026-02-05
BETAMETHASONE DIPROPIONATE 2026-01-26
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
LOPERAMIDE HYDROCHLORIDE 2025-12-29
HYDROXYZINE HYDROCHLORIDE 2025-12-16
ISOPROTERENOL HYDROCHLORIDE 2025-12-10
LOPERAMIDE HYDROCHLORIDE 2025-11-17
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
TRIAMCINOLONE ACETONIDE 2025-10-17
CHLORPROMAZINE HYDROCHLORIDE 2025-10-10
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 67%
2 drugs
Respiratory 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (38)
CHLORPROMAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE ISOPROTERENOL HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE TRIAMCINOLONE ACETONIDE FLUOCINOLONE ACETONIDE DICYCLOMINE HYDROCHLORIDE THEOPHYLLINE HYDROCORTISONE TETRACYCLINE HYDROCHLORIDE PROCHLORPERAZINE EDISYLATE THIORIDAZINE HYDROCHLORIDE PROCHLORPERAZINE GENTAMICIN SULFATE ERYTHROMYCIN ETHYLSUCCINATE NYSTATIN AND TRIAMCINOLONE ACETONIDE FLURANDRENOLIDE THIOTHIXENE HYDROCHLORIDE SERAX ERYTHROMYCIN ESTOLATE CODAMINE BROMPHENIRAMINE MALEATE ISOETHARINE HYDROCHLORIDE TRIPLE SULFA BUTABARB ISOETHARINE MESYLATE PROMETH FORTIS PIPERAZINE CITRATE TRIPROLIDINE HYDROCHLORIDE TRIMETH/SULFA METHDILAZINE HYDROCHLORIDE HYDRAMINE LOMANATE TRIMEPRAZINE TARTRATE BROMANYL FLUOCET MYKINAC BROMANATE DM
Company Info
- First Approval
- 1965-06-04
- Latest
- 2002-12-23
- Applications
- 61